1
|
Howley P and Lowy D: Papillomaviruses and
their replicationFields Virology. Knipe DM and Howley PM:
Lippincott Williams & Wilkins; Philadelphia, PA: pp. 2197–2229.
2001
|
2
|
Coussens LM and Werb Z: Inflammation and
cancer. Nature. 420:860–867. 2002. View Article : Google Scholar : PubMed/NCBI
|
3
|
Hold GL and El-omar EM: Genetic aspects of
inflammation and cancer. Biochem J. 410:225–235. 2008. View Article : Google Scholar : PubMed/NCBI
|
4
|
Vane J: Towards a better aspirin. Nature.
367:215–216. 1994. View
Article : Google Scholar : PubMed/NCBI
|
5
|
FitzGerald GA and Patrono C: The coxibs,
selective inhibitors of cyclooxygenase-2. N Engl J Med.
345:433–442. 2001. View Article : Google Scholar : PubMed/NCBI
|
6
|
Gierse JK, Hauser SD, Creely DP, Koboldt
C, Rangwala SH, Isakson PC and Seibert K: Expression and selective
inhibition of the constitutive and inducible forms of human
cyclo-oxygenase. Biochem. J. 305:479–484. 1995. View Article : Google Scholar : PubMed/NCBI
|
7
|
Gruber BM, Bubko I, KrzysztonRussjan J and
Anuszewska EL: Synergistic action of doxorubicin and sulindac in
human cervix carcinoma cells - studies on possible mechanisms. Med
Sci Monit. 16:BR45–BR51. 2010.PubMed/NCBI
|
8
|
Crum C, Muovo G and Lee K: The
cervixSternberg S: Diagnostic Surgical Pathology. 3rd. Lippincott
Williams & Wilkins; Philadelphia, PA: pp. 2155–2202. 1999
|
9
|
Bauman DR, Steckelbroeck S and Penning TM:
The roles of Aldo-Keto reductases in steroid hormone action. Drug
News Perspect. 17:563–578. 2004. View Article : Google Scholar : PubMed/NCBI
|
10
|
Bauman DR, Rudnick SI, Szewczuk LM, et al:
Development of nonsteroidal anti-inflammatory drug analogs and
steroid carboxylates selective for human aldo-keto reductase
isoforms: Potential antineoplastic agents that work independently
of cyclooxygenase isozymes. Mol Pharmacol. 67:60–68. 2005.
View Article : Google Scholar : PubMed/NCBI
|
11
|
Soriano-Hernández AD, Galvan-Salazar HR,
Montes-Galindo DA, et al: Antitumor effect of meclofenamic acid on
human androgen-independent prostate cancer: A preclinical
evaluation. Int Urol Nephrol. 44:471–477. 2012. View Article : Google Scholar : PubMed/NCBI
|
12
|
Rahbari R, Sheahan T, Modes V, Collier P,
Macfarlane C and Badge RM: A novel L1 retrotransposon marker for
HeLa cell line identification. Biotechniques. 46:277–284.
2009.PubMed/NCBI
|
13
|
Watson DM: The Virginian-Pilot: HeLa
Cancer cells killed Henrietta Lacks - then made her immortal.
http://hamptonroads.com/2010/05/cancer-cells-killed-henrietta-lacks-then-made-her-immortalAccessed.
September 17–2014.
|
14
|
Kim KM, Song JJ, An JY, Kwon YT and Lee
YJ: Pretreatment of acetylsalicylic acid promotes tumor necrosis
factor-related apoptosis-inducing ligand-induced apoptosis by
down-regulating BCL-2 gene expression. J Biol Chem.
280:41047–41056. 2005. View Article : Google Scholar : PubMed/NCBI
|
15
|
Blaheta RA, Weich E, Marian D,
BereiterHahn J, Jones J, Jonas D, Michaelis M, Doerr HW and Cinatl
J Jr: Human cytomegalovirus infection alters PC3 prostate carcinoma
cell adhesion to endothelial cells, and extracellular matrix.
Neoplasia. 8:807–816. 2006. View Article : Google Scholar : PubMed/NCBI
|
16
|
Kim SH, Song SH, Kim SG, Chun KS, Lim SY,
Na HK, Kim JW, Surh YJ, Bang YJ and Song YS: Celecoxib induces
apoptosis in cervical cancer cells independent of cyclooxygenase
using NF-kappaB as a possible target. J Cancer Res Clin Oncol.
130:551–560. 2004. View Article : Google Scholar : PubMed/NCBI
|
17
|
Al-Nasiry S, Geusens N, Hanssens M, Luyten
C and Pijnenborg R: The use of Alamar Blue assay for quantitative
analysis of viability, migration and invasion of choriocarcinoma
cells. Hum Reprod. 22:1304–1309. 2007. View Article : Google Scholar : PubMed/NCBI
|
18
|
Stephenson RA, Dinney CP, Gohji K, Ordonez
NG, Killion JJ and Fidler IJ: Metastatic model for human prostate
cancer using orthotopic implantation in nude mice. J Natl Cancer
Inst. 84:951–957. 1992. View Article : Google Scholar : PubMed/NCBI
|
19
|
Koziol JA, Maxwell DA, Fukushima M,
Colmerauer ME and Pilch YH: A distribution-free test for
tumor-growth curve analyses with application to an animal tumor
immunotherapy experiment. Biometrics. 37:383–390. 1981. View Article : Google Scholar : PubMed/NCBI
|
20
|
SAGARPA: Technical specifications for the
care and use of laboratory animals of the Mexican Official Standard
(NOM-062-ZOO-1999). https://www.fmvz.unam.mx/fmvz/principal/archivos/062ZOO.PDF(In
Spanish). Accessed. June 17–2015.
|
21
|
Quann EJ, Khwaja F, Zavitz KH and Djakiew
D: The aryl propionic acid R-flurbiprofen selectively induces
p75NTR-dependent decreased survival of prostate tumor cells. Cancer
Res. 67:3254–3262. 2007. View Article : Google Scholar : PubMed/NCBI
|
22
|
Adachi M, Sakamoto H, Kawamura R, Wang W,
Imai K and Shinomura Y: Nonsteroidal anti-inflammatory drugs and
oxidative stress in cancer cells. Histol Histopathol. 22:437–442.
2007.PubMed/NCBI
|
23
|
Sakonlaya D, Tapanadechopone P, Poomkokruk
A and Charoenvilaisiri S: Do NSAID's Inhibit growth of precancerous
cervical cells in vitro? J Med Assoc Thai. 95:(Suppl 1). S65–S73.
2012.PubMed/NCBI
|
24
|
Wang AH, Tian XY, Yu JJ, Mi JQ, Liu H and
Wang RF: Celecoxib radiosensitizes the human cervical cancer HeLa
cell line via a mechanism dependent on reduced cyclo-oxygenase-2
and vascular endothelial growth factor C expression. J Int Med Res.
40:56–66. 2012. View Article : Google Scholar : PubMed/NCBI
|
25
|
Gaffney DK, Winter K, Dicker AP, Miller B,
Eifel PJ, Ryu J, Avizonis V, Fromm M, Small W and Greven K:
Efficacy and Patterns of failure for locally advanced cancer of the
cervix treated with celebrex (celecoxib) and chemoradiotherapy in
RTOG 0128. Int J Radiat Oncol Biol Phys. 69:111–117. 2007.
View Article : Google Scholar : PubMed/NCBI
|